(Q40746321)

23 September 2017

1 reference

title

Coronary angioplasty in acute myocardial infarction: primary, immediate adjunctive, rescue, or deferred adjunctive approach? (English)

1 reference

acute myocardial infarction

23 September 2017

main subject

1 reference

R D Simari

1

1 reference

23 September 2017

P B Berger

2

1 reference

23 September 2017

M R Bell

3

1 reference

23 September 2017

R J Gibbons

4

1 reference

23 September 2017

D R Holmes

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

23 September 2017

1 reference

23 September 2017

volume

69

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

346-358

1 reference

The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Streptokinase in acute myocardial infarction. European Cooperative Study Group for Streptokinase Treatment in Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Thrombolysis in acute myocardial infarction: treatment of the underlying coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Percutaneous transluminal coronary angioplasty, alone or in combination with streptokinase therapy, during acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Emergency percutaneous transluminal coronary angioplasty without thrombolysis as initial therapy in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Catheterization laboratory events and hospital outcome with direct angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Late restenosis after emergent coronary angioplasty for acute myocardial infarction: comparison with elective coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Multicenter registry of angioplasty therapy of cardiogenic shock: initial and long-term survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Failed direct coronary angioplasty for acute myocardial infarction: in-hospital outcome and predictors of death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Usefulness of angioplasty during acute myocardial infarction in patients with prior coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Primary angioplasty in myocardial infarction: Assessment of improved myocardial perfusion with technetium-99m isonitrile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Determinants of infarct size in reperfusion therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Eligibility for intravenous thrombolysis in suspected acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Sudden paradoxic clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Angiographic validation of bedside markers of reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962220-4

10.1016/S0025-6196(12)62220-4

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference